Maternal and Fetal Outcomes after Interferon Exposure: A Systematic Review and Meta-Analysis
M Zhang, S Fu, D Ren, N Yao, T Ni, Y Feng… - Available at SSRN … - papers.ssrn.com
Background: Interferon (IFN) is widely applied in viral hepatitis and multiple oncologic
diseases. Whereas, there is considerable controversy on how to deal with unintended …
diseases. Whereas, there is considerable controversy on how to deal with unintended …
Maternal and fetal outcomes after interferon exposure during pregnancy: a systematic review with meta-analysis
M Zhang, S Fu, D Ren, Y Wu, N Yao, T Ni… - … in Reproductive Health, 2021 - frontiersin.org
Interferon (IFN) treatment is widely applied in viral hepatitis and multiple myeloproliferative
diseases. However, there is considerable controversy on how to deal with unintended …
diseases. However, there is considerable controversy on how to deal with unintended …
A systematic review of the fetal safety of interferon alpha
PY Brojeni, I Matok, FG Bournissen, G Koren - Reproductive toxicology, 2012 - Elsevier
BACKGROUND: Interferon alpha (IFN) is an effective treatment for a variety of conditions
including essential thrombocythemia (ET), chronic myelocytic leukemia, Hepatitis B and C …
including essential thrombocythemia (ET), chronic myelocytic leukemia, Hepatitis B and C …
Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Preg study conducted in Finland and …
K Hellwig, Y Geissbuehler, M Sabidó, C Popescu… - Neurology, 2019 - AAN Enterprises
Objective: To assess the prevalence of pregnancy and infant outcomes in interferon-beta
(IFNβ) exposed pregnant women with multiple sclerosis (MS) from European IFNβ …
(IFNβ) exposed pregnant women with multiple sclerosis (MS) from European IFNβ …
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX® Pregnancy Exposure Registry
B Weinstock-Guttman, AP Ross, J Planton… - Drugs-Real World …, 2023 - Springer
Abstract Background and Objectives There is a lack of well-controlled US studies of
intramuscular (IM) interferon beta (IFNβ)-1a use in pregnant women with multiple sclerosis; …
intramuscular (IM) interferon beta (IFNβ)-1a use in pregnant women with multiple sclerosis; …
Pregnancy and infant outcomes with interferon beta: data from the European Interferon Beta Pregnancy Registry and population based registries in Finland and …
K Hellwig, Y Geissbuehler, M Sabidó… - … sclerosis and related …, 2018 - msard-journal.com
Background: Women with multiple sclerosis (MS) are often diagnosed/treated at
childbearing age. Until recently, data on MS and interferon beta (IFNβ) exposure during …
childbearing age. Until recently, data on MS and interferon beta (IFNβ) exposure during …
The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort
Objective: To determine whether interferon therapy during human pregnancy increases
reproductive risks in women. Methods: This longitudinal, controlled cohort study consisted of …
reproductive risks in women. Methods: This longitudinal, controlled cohort study consisted of …
Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden
KM Hakkarainen, R Juuti, S Burkill… - Therapeutic …, 2020 - journals.sagepub.com
Background Our aim was to estimate and compare the prevalence of adverse pregnancy
outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta …
outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta …
Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A register-based drug utilisation study in Finland and Sweden
MS Espin, K Suzart-Woischnik, N Grimes… - Multiple Sclerosis …, 2022 - msard-journal.com
Background: Previous studies showed no increased risk of interferon beta use before or
early in pregnancy among women with multiple sclerosis (MS). However, knowledge about …
early in pregnancy among women with multiple sclerosis (MS). However, knowledge about …
Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: a register-based cohort study in Finland and Sweden among …
P Vattulainen, S Burkill, Y Geissbuehler… - Multiple Sclerosis …, 2019 - diva-portal.org
Objectives: To determine the prevalence of categorical measures of birth weight for
gestational age (small for gestational age (SGA), large for gestational age (LGA)), low birth …
gestational age (small for gestational age (SGA), large for gestational age (LGA)), low birth …